Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 21.55
(-0.23%)
CNY 21.55
(-0.23%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 21.25 Million CNY | 73.06% |
| 2022 | 12.28 Million CNY | 530.86% |
| 2021 | 1.94 Million CNY | -58.73% |
| 2020 | 4.71 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 8.36 Million CNY | 0.0% |
| 2024 Q2 | 17.74 Million CNY | 0.0% |
| 2024 Q1 | 19.52 Million CNY | 0.0% |
| 2023 FY | 21.25 Million CNY | 73.06% |
| 2023 Q3 | 14.97 Million CNY | 18.73% |
| 2023 Q1 | 14.14 Million CNY | 15.16% |
| 2023 Q4 | 21.25 Million CNY | 41.98% |
| 2023 Q2 | 12.6 Million CNY | -10.85% |
| 2022 Q1 | 1.48 Million CNY | -23.83% |
| 2022 FY | 12.28 Million CNY | 530.86% |
| 2022 Q4 | 12.28 Million CNY | -3.98% |
| 2022 Q3 | 12.79 Million CNY | 2449.59% |
| 2022 Q2 | 501.72 Thousand CNY | -66.17% |
| 2021 Q3 | 1.75 Million CNY | -37.91% |
| 2021 Q4 | 1.94 Million CNY | 10.67% |
| 2021 Q2 | 2.83 Million CNY | -27.63% |
| 2021 Q1 | 3.91 Million CNY | -17.0% |
| 2021 FY | 1.94 Million CNY | -58.73% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 4.71 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | 4.71 Million CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 671.68 Million CNY | 96.835% |
| Zhejiang Zhenyuan Share Co., Ltd. | 54.96 Million CNY | 61.325% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 94.96 Million CNY | 77.618% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 419.53 Million CNY | 94.933% |
| Yifan Pharmaceutical Co., Ltd. | 812.04 Million CNY | 97.382% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | - CNY | -Infinity% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.64 Billion CNY | 99.197% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 126.5 Million CNY | 83.197% |
| Boai NKY Medical Holdings Ltd. | 32.61 Million CNY | 34.826% |